Articles from Partnership for Safe Medicines

The Partnership for Safe Medicines (PSM) filed a citizen petition urging the U.S. Food and Drug Administration to block compounding of unapproved peptides and to disregard the advisory committee vote that recommended allowing them, on grounds that the committee was constituted in violation of the Federal Advisory Committee Act (FACA) and the Ethics in Government Act (EIGA), federal laws that govern conflicts of interest in agency advisory proceedings.

The Partnership for Safe Medicines today published a report outlining solutions to protect patients from the risks of a growing compounded GLP-1 marketplace. A Call to Action: Restoring and Strengthening America’s Patient Safety System serves as a detailed plan for policymakers and regulators to uphold the gold standard system that protects Americans from untested and unsafe medicines.

The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S. from foreign sources despite U.S. laws forbidding them from coming through the border. The U.S. Food and Drug Administration (FDA) has warned against drug compounders’ use of unauthorized bulk drug ingredients, semaglutide and tirzepatide, which are being imported into the U.S. from several countries, including China.

Today, the Partnership for Safe Medicines unveiled the results of a national public opinion poll that shows more than 90% of likely voters are concerned about the safety, regulation, and efficacy of compounded medications for diabetes and obesity (or weight loss). Ninety percent say the FDA should use their existing authority to ensure these compounded weight loss drugs are safe.

Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the U.S. Food and Drug Administration’s final decision to approve Florida’s Canadian drug importation plan.

The Partnership for Safe Medicines, a public health group committed to the safety of pharmaceutical medicines, applauds the International Criminal Police Organization (INTERPOL) for organizing the seizure of over $11 million in counterfeit medicines during Operation Pangea XV, an initiative to combat the global trafficking of counterfeit pharmaceuticals marketed and sold online. During the week-long annual operation, law enforcement officers from 94 countries fanned out to investigate and shut down websites selling illicit medical products.